In addition, reports have also discovered that FBXO22 inhibits human renal cancer metastasis and makes non-small cell lung cancer (NSCLC) cells sensitive to ionizing radiation (IR) and cisplatin [30]. This evidence concerns the gene FBXO22 and non-small cell lung carcinoma.